Takeda Pharmaceutical Co Ltd (NYSE:TAK)
| 14.15 Delayed Data As of 4:00pm ET |  +0.125 / +0.89%Today’s Change | 13.19 Today|||52-Week Range 17.15 | -9.33% Year-to-Date |
Latest TAK News | Press Releases
| Are Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now? Nov 17 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 14.02 |
| Today’s open | 14.09 |
| Day’s range | 14.05 - 14.15 |
| Volume | 1,965,276 |
| Average volume (3 months) | 1,988,689 |
| Market cap | $44.1B |
Data as of 4:00pm ET, 11/30/2023
Growth & Valuation
| Earnings growth (last year) | +15.12% |
| Earnings growth (this year) | -43.64% |
| Earnings growth (next 5 years) | -3.00% |
| Revenue growth (last year) | -6.43% |
| P/E ratio | 34.5 |
| Price/Sales | 1.74 |
| Price/Book | 0.91 |
Financials
| Next reporting date | February 1, 2024 |
| EPS forecast (this quarter) | $0.16 |
| Annual revenue (last year) | $29.7B |
| Annual profit (last year) | $2.3B |
| Net profit margin | 7.87% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Osaka, Osaka |
Forecasts
